首页|r-tPA与尿激酶对急性高危型肺栓塞的介入治疗效果比较

r-tPA与尿激酶对急性高危型肺栓塞的介入治疗效果比较

扫码查看
目的 研究r-tPA 与尿激酶药物在介入溶栓治疗中对急性高危型肺栓塞患者不同疗效的比较.方法 对22 名急性高危型肺栓塞患者的临床资料进行分析,将其分为r-tPA 组(10 人)和尿激酶组(12 人),记录2 组的溶栓时间,并比较治疗前后2 组患者的血压、心率、动脉血氧分压、血红蛋白和肺动脉压的变化.结果 尿激酶组患者溶栓时间明显长于r-tPA 组患者的溶栓时间( P<.0.05).2组患者治疗前后血压、心率、动脉血氧分压均有较大改善( P<.0.05);尿激酶组患者手术治疗后肺动脉压较治疗前显著降低( P<.0.05),r-tPA组患者手术治疗后肺动脉压降低程度较小,差异无统计学意义;2组病例治疗后血红蛋白降低程度较小,差异无统计学意义.结论 采用r-tPA与尿激酶介入治疗对急性高危型肺栓塞患者皆有一定疗效,但采用r-tPA可明显减少溶栓时间,并降低出血风险.
Comparison of curative effect between r-tPA application and urokinase in the interventional therapy for acute and severe pulmonary embolism
Objective To study the different curative effect between r-tPA application and urokinase in the interventional therapy for acute and severe pulmonary embolism.Methods Analyzed the clinical date of 22 cases acute and severe pulmonary embolism patients,and classified them into two groups according to the application of r-tPA and urokinase to compare the changes of their blood pressure,heart rate,arterial partial pressure of oxygen,hemachrome and pulmonary arterial pressure before and after therapy,meanwhile,record the thrombolysis time that the two groups took.Results The thrombolysis effect time adopting urokinase was remarkably longer than that thrombolysis adopting r-tPA(P<0.05); The blood pressure,heart rate,arterial partial pressure of oxygen of the two groups gained remarkable improvement after therapy(P<0.05).The pulmonary arterial pressure of the urokinase group dropped obviously after operation(P<0.05),while the r-tPA group dropped not so significantly after operation.The hemachrome of the two groups did not dropped significantly after operation.Conclusion The r-tPA and urokinase are both effective to interventional therapy for acute and severe pulmonary embolism,while r-tPA can clearly shorten the time in thrombolysis and could reduce any bleeding risk.

acute and severe pulmonary embolismthrombolytic therapytissue plasminogen activatorurokinase-type plasminogen activator

程丹、王宏、梁宗安

展开 >

浙江省海宁市中心医院 呼吸内科,浙江 海宁 314408

浙江省人民医院 呼吸内科,浙江 杭州 310014

四川大学华西医院呼吸与危重症医学科,四川 成都 643000

急性高危型肺栓塞 溶栓疗法 组织性纤溶酶原激活物 尿纤溶酶原激活物

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.(4)
  • 2
  • 8